| Nalini Gumbs, APRN | |
|
400 N Tampa St Fl 15, Tampa, FL 33602-4730 | |
| (800) 803-3370 | |
| Not Available |
| Full Name | Nalini Gumbs |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 400 N Tampa St Fl 15, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053722843 | NPI | - | NPPES |
| ARNP9180679 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN9180679 (Florida) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | APRN9180679 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health System Sunbelt Inc | 3274657721 | 55 |
News Archive
The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.
Antibiotic prophylaxis regimens are becoming less effective at preventing surgical site infections following colorectal surgery, researchers at the Center for Disease Dynamics, Economics & Policy and Princeton University determined through a systematic review of available literature.
Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed with the un-formulated active ingredient, hydrocodone, as modified according to a host of patent applications filed by Pisgah Labs with the United States Patent and Trademark Office (http://www.uspto.gov).
The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 7 days ago
| Entity Name | Adventist Health System/sunbelt, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073565610 PECOS PAC ID: 6406849256 Enrollment ID: O20040406001849 |
News Archive
The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.
Antibiotic prophylaxis regimens are becoming less effective at preventing surgical site infections following colorectal surgery, researchers at the Center for Disease Dynamics, Economics & Policy and Princeton University determined through a systematic review of available literature.
Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed with the un-formulated active ingredient, hydrocodone, as modified according to a host of patent applications filed by Pisgah Labs with the United States Patent and Trademark Office (http://www.uspto.gov).
The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 7 days ago
| Entity Name | Adventist Health System Sunbelt Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427296730 PECOS PAC ID: 3274657721 Enrollment ID: O20100903000981 |
News Archive
The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.
Antibiotic prophylaxis regimens are becoming less effective at preventing surgical site infections following colorectal surgery, researchers at the Center for Disease Dynamics, Economics & Policy and Princeton University determined through a systematic review of available literature.
Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed with the un-formulated active ingredient, hydrocodone, as modified according to a host of patent applications filed by Pisgah Labs with the United States Patent and Trademark Office (http://www.uspto.gov).
The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nalini Gumbs, APRN 400 N Tampa St Fl 15, Tampa, FL 33602-4730 Ph: (800) 803-3370 | Nalini Gumbs, APRN 400 N Tampa St Fl 15, Tampa, FL 33602-4730 Ph: (800) 803-3370 |
News Archive
The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.
Antibiotic prophylaxis regimens are becoming less effective at preventing surgical site infections following colorectal surgery, researchers at the Center for Disease Dynamics, Economics & Policy and Princeton University determined through a systematic review of available literature.
Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed with the un-formulated active ingredient, hydrocodone, as modified according to a host of patent applications filed by Pisgah Labs with the United States Patent and Trademark Office (http://www.uspto.gov).
The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
› Verified 7 days ago
Charmaine Henry, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15511 N Florida Ave Ste 401, Tampa, FL 33613 Phone: 813-963-3124 Fax: 813-908-7808 | |
Ms. Bridget Shoulders-odom, MS, ACNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Bld, Tampa, FL 33612 Phone: 813-972-2000 | |
Ms. Rhea Arlene Hurwitz, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3001 W Martin Luther King Boulevard, Tampa, FL 33607 Phone: 813-554-8511 | |
Dr. Leigh Nicole Montejo, DNP, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9527 Delaney Creek Blvd, Tampa, FL 33619 Phone: 813-615-5230 | |
Mrs. Dawn Elizabeth White, NP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 2901 W Saint Isabel St, Suite A3, Tampa, FL 33607 Phone: 813-872-4401 | |
Crystal Elaine Blair, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Tampa, FL 33612 Phone: 813-972-2000 | |
Courtney Pariso, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3010 E 138th Ave, Suite 12, Tampa, FL 33613 Phone: 813-975-2800 Fax: 813-977-7631 |